Neuburgh Advisers’s Bristol-Myers Squibb BMY Stock Holding History

Neuburgh Advisers’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$16.5M	Buy	325,380 +101,116	+45%	+$4.75M	0.51%	37
2019 Q2	$10.2M	Buy	224,264 +168,708	+304%	+$7.86M	0.33%	69
2019 Q1	$2.65M	Buy	55,556 +22,984	+71%	+$1.14M	0.09%	185
2018 Q4	$1.69M	Sell	32,572 -4,556	-12%	-$245K	0.07%	214
2018 Q3	$2.31M	Sell	37,128 -578	-2%	-$34.3K	0.07%	199
2018 Q2	$2.09M	Sell	37,706 -7,242	-16%	-$391K	0.07%	210
2018 Q1	$2.84M	Buy	44,948 +7,242	+19%	+$466K	0.1%	172
2017 Q4	$2.31M	Buy	37,706 +17,578	+87%	+$1.1M	0.08%	184
2017 Q3	$1.28M	Buy	+20,128	New	+$1.18M	0.05%	240
2017 Q1	–	Sell	-21,624	Closed	-$1.26M	–	883
2016 Q4	$1.26M	Buy	+21,624	New	+$1.18M	0.06%	209

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Neuburgh Advisers's BMY Position: Q3 2019 in Review

Neuburgh Advisers increased its Bristol-Myers Squibb (BMY) stake by 45% in Q3 2019, buying an estimated $4.75M and bringing the position to 325,380 shares worth $16.5M. The position accounts for 0.51% of the portfolio, ranked #37.

Neuburgh Advisers first reported a position in BMY in Q4 2016 and has held it in 10 quarters since. 1,813 funds tracked by Wall St. Rank hold BMY as of Q3 2019.

Neuburgh Advisers held 325,380 shares of Bristol-Myers Squibb worth $16.5M as of Q3 2019.
Neuburgh Advisers bought 101,116 Bristol-Myers Squibb shares in Q3 2019, an estimated $4.75M.
Bristol-Myers Squibb made up 0.51% of Neuburgh Advisers's portfolio in Q3 2019, its #37 holding.
Neuburgh Advisers first reported a position in Bristol-Myers Squibb in Q4 2016 and has held it in 10 quarters since.
1,813 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2019.

Based on Neuburgh Advisers's 13F filing for Q3 2019, filed 14 Nov 2019.